Search clinical trials for: 177Lu-FAP-2286

Total 3424 results

Glenn Bauman
London Health Sciences Foundation

Active, not recruiting

Radioligand fOr locAl raDiorecurrent proStaTe cancER (ROADSTER)

Prostate Cancer

Canada
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver

Neuroendocrine Tumors | Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors

United States
Excel Diagnostics and Nuclear Oncology Center

Withdrawn

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. (PUTNET)

Neuroendocrine Tumors | Pheochromocytoma | Paraganglioma | Unknown Primary Tumors | Pulmonary Neuroendocrine Neoplasm | Thymus Carcinoid | Neuroendocrine Skin Carcinoma | Neuroendocrine Breast Tumor | Neuroendocrine Carcinoma Metastatic | Neuroendocrine Neoplasm of Ovary

United States
Samuel Lunenfeld Research Institute, Mount Sinai...
University of Toronto

Completed

Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatment

Postpartum Hemorrhage

Canada
Nordic Nanovector

Withdrawn

Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)

Non-Hodgkin Lymphoma

Germany
University of Warmia and Mazury
National Center for Research and Development, Poland; Medical University of... and other collaborators

Unknown

Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer

Neuroendocrine Tumors

Poland
New York Glaucoma Research Institute

Unknown

A Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Surgical Intervention

Glaucoma

United States
Erasmus Medical Center

Recruiting

Biomarker Identification of Radionuclide Therapy-induced Radiation Responses (Radio-Marker)

Neuroendocrine Tumors

Netherlands
Memorial Sloan Kettering Cancer Center
Novartis Pharmaceuticals

Active, not recruiting

A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer

Prostate Cancer

United States
Ebrahim S Delpassand
Excel Diagnostics and Nuclear Oncology Center

Completed

177Lutetium-DOTA-Octreotate Therapy in Somatostatin Receptor-Expressing Neuroendocrine Neoplasms

Neuroendocrine Tumors

United States
Endocyte

Terminated

Lutetium-177 (Lu177) Prostate-Specific Antigen (PSMA)-Directed EndoRadiotherapy (RESIST-PC)

Metastatic Castration Resistant Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC

Terminated

Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer

Rectal Cancer | Colon Cancer

United States
Recep Tayyip Erdogan University

Enrolling by invitation

Evaluation of the Effects of Four Different Flap Designs on Tissue Healing in Lower Third Molar Surgery

Soft Tissue Injuries

Turkey
The National Institute of Lymphology
The DrMarga Practice Group; The Center for Restorative Breast Surgery, LLC

Unknown

Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment

Breast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | Congenital Lymphedema | Acquired Lymphedema

United States
Radboud University Medical Center
Advanced Accelerator Applications; Prostaatkankerstichting

Recruiting

Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer (Bullseye)

Prostate Cancer

Netherlands, Cyprus
Peking University

Unknown

Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients

Neuroendocrine Tumors

China
Lund University Hospital

Completed

A Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors (ILUMINET)

Neuroendocrine Tumors | Liver Metastases

Sweden
Calithera Biosciences, Inc

Completed

Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors

Advanced Solid Tumors

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Withdrawn

Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies

Malignant Neoplasms of Female Genital Organs | Malignant Neoplasms of Lip Oral Cavity and Pharynx | Malignant Neoplasms of Digestive Organs | Malignant Neoplasms of Male Genital Organs
National Cancer Institute (NCI)

Completed

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery

Refractory Pancreatic Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2

United States
NYU Langone Health

Recruiting

Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma

Meningioma

United States
Institut Claudius Regaud
Advanced Accelerator Applications

Recruiting

A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors. (NEUROBLU 02)

Neuroblastoma

France
Novartis Pharmaceuticals

Active, not recruiting

LUTATHERA Injection General Use Result Survey

Somatostatin Receptor-positive Neuroendocrine Tumor

Japan
National Cancer Institute (NCI)

Active, not recruiting

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Malignant Glioma | Recurrent Childhood Ependymoma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Solid Neoplasm | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent... and other conditions

United States, Puerto Rico
The Second Hospital of Tangshan
Chinese PLA General Hospital; The Second Hospital of Qinhuangdao

Completed

Treatment of Painful Digital Neuroma Using A Pedicled Nerve Flap

Painful Digital Neuroma

China
The Netherlands Cancer Institute
UMC Utrecht; Advanced Accelerator Applications

Recruiting

EBRT + Lu-PSMA for N1M0 Prostate Cancer (PROQURE-1)

Prostatic Neoplasm

Netherlands
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Neuroendocrine Tumors

China
Novartis Pharmaceuticals

Recruiting

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

Glioblastoma

Spain, Switzerland, France, Portugal, United States
University of Alabama at Birmingham
SmartFoods, Inc.

Completed

Effects of Various Higher Fat and Lower Fat Snacks on Cardiovascular Risk Factors in Men and Women.

Hypercholesterolemia
Imperial College London
Medical Research Council; University of Cambridge

Recruiting

HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer

Breast Cancer

United Kingdom
Endocyte

Completed

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer (VISION)

Prostate Cancer

United States, United Kingdom, Canada, Netherlands, Sweden, France, Puerto Rico, Belgium, Denmark, Germany
Advanced Accelerator Applications

Approved for marketing

EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx

Neuroendocrine Tumors

United States
Oslo University Hospital

Completed

Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons

Cardiovascular Disease | Cardiovascular Risk Factors | Dietary Modification

Norway
Craig Hospital
National Institute on Disability, Independent Living, and Rehabilitation...

Enrolling by invitation

Improving Upper Extremity Function and Trunk Stability After Cervical Spinal Cord Injury (SCI)

Cervical Spinal Cord Injury

United States
USDA, Western Human Nutrition Research Center

Terminated

Energy Expenditure and Substrate Oxidation in a Whole Room Calorimeter

Obesity | Overweight | Body Weight

United States
UConn Health
Medical College of Wisconsin

Completed

Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis (BRB)

Ulcerative Colitis

United States
Novartis Pharmaceuticals

Not yet recruiting

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Metastatic Neuroendocrine Prostate Cancer
Peter MacCallum Cancer Centre, Australia

Recruiting

177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer (LuPARP)

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Australia
Peter MacCallum Cancer Centre, Australia

Completed

PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr) (PRINCE)

Metastatic Castration Resistant Prostate Cancer

Australia
Jilin University

Recruiting

18F-FAPI PET/CT in Patients With Various Types of Cancer

Cancer

China
Vastra Gotaland Region

Recruiting

Reconstructions With Back Donor Site Flaps and Validation of Quality of Life Scales

Breast Cancer

Sweden
Samsung Medical Center

Completed

Efficacy of Subfascial Approach in Thyroidectomy to Quality of Life in Thyroid Disease Patients

Thyroid Cancer

Korea, Republic of
3M
Eurotrials Brasil Consultores Cientificos Ltda

Completed

Passive Disinfection Cap Compliance Study

Infection, Hospital

United States
The Second Hospital of Tangshan
Chinese PLA General Hospital; The Second Hospital of Qinhuangdao

Completed

Sensory Reconstruction of Finger Pulp Defect Using a Dorsal Digital Island Flap

Trauma
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)

Advanced Cancer
Affiliated Hospital of Jiangnan University

Recruiting

Tracer Targeting FAP PET Imaging in Patients

Cancer

China
Cantonal Hospital of St. Gallen

Completed

Limberg-flap: Prospective Data Collection

Pilonidal Sinus

Switzerland
Inje University

Not yet recruiting

Mini-flap BABA (Bilateral Axillo-breast Approach) Robotic Thyroidectomy is Safe

Thyroid Nodule

Korea, Republic of
Medical University of South Carolina

Completed

Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence

Medication Adherence

United States
Potrero Medical
Emory University; University of Arkansas; Central Arkansas Veterans Healthcare...

Terminated

Targeting Abdominal Perfusion Pressure in Septic Shock (MAP-APP)

Septic Shock | Acute Kidney Injury | Resuscitations

United States

Search clinical trials for: 177Lu-FAP-2286

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations